Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > GUDATE

View:

Post by Doccole on Apr 23, 2021 8:36am

GUDATE

Knight just bought a drug for Alzheimer's. Dano has been talking about Alzheimer's. We have a connection with GUD. How could this synergies play out?

131

Comment

Comment by WalkOverTheStrt on Apr 23, 2021 9:19am

Doc - years away from any human trial... stay focused on what matters - PH3 and 352 to human trials... mgmt has proven they can manage too many balls in the air... zero confidence adding another preclinical trial (unless someone else runs it) is in their capabilities with 352 and oten in human trials....

106

Comment

Comment by Doccole on Apr 23, 2021 9:33am

Years away no doubt, but one can't question the potential in partnership. This is all speculation for fun. Short term I understand the catalysts.

Comment

Comment by MrMugsy on Apr 23, 2021 9:45am

That's a good question Doccole. Not sure. I would assume GUD wants to get their hands on ATE's future products in Latin America but not sure if they can agree on a price. I'm sure GUD's first interest is in bumping up revenue and enjoy the synergies of a Canada/LATAM combo. I'm thinking ATE could easily use a generic to build their future drug - don't really need ...more

111

Comment